-
Lilly's AD new drug is only one step away from being approved in the United States, and Chinese pharmaceutical companies are also developing it
The drug development for Alzheimer's disease (AD), which is considered a "research and development black hole," is accelerating, and another A β drug is about to be approved. On June 10th local time ... -
AstraZeneca Wang Lei: "Currently is the best time for Chinese pharmaceutical companies to go global
'Cold Winter' is one of the most commonly used terms to describe the pharmaceutical industry at present. Due to the combined influence of multiple factors, the growth rate of pharmaceutical equipment ...